Lv3
268 积分 2022-11-17 加入
A0078 Omitting pelvic lymph node dissection during radical cystectomy for NMIBC: An interim analysis of a prospective, multicenter, randomized trial
5天前
已关闭
Comparison of Perioperative Chemotherapy Regimens for Muscle‐Invasive Bladder Cancer: A Reconstructed Individual Patient Data Analysis of Phase 3 Trials
5天前
已完结
A0090 Disitamab vedotin alone or combined with PD-1 inhibitors in high-risk non–muscleinvasive bladder cancer: A multicenter real-world study
5天前
已关闭
Advances in the management of localized bladder cancers
5天前
已完结
Development and external validation of a nomogram predicting cancer-specific mortality-free survival after trimodal therapy in muscle-invasive bladder cancer
1个月前
已完结
Association of Weight Loss and BMI on PSA Levels and Overall Survival in Veterans With Metastatic Castrate‐Resistant Prostate Cancer
1个月前
已完结
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274
1个月前
已完结
A Deep Prostate-specific Antigen Response to Darolutamide plus Androgen Deprivation Therapy Is Associated with Better Clinical Outcomes in the Phase 3 ARANOTE Trial in Patients with Metastatic Hormone-sensitive Prostate Cancer
6个月前
已关闭
Oncological and Survival Outcomes of Pelvic Lymph Node Dissection in Patients with Nonmuscle Invasive Bladder Cancer Undergoing Radical Cystectomy Using the National Cancer Database
6个月前
已完结
Life Expectancy of Renal Cell Carcinoma with Variant Histology
6个月前
已完结
皖公网安备34019202002308
